Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Preferred Shares: 2015-2024

Historic Preferred Shares for CorMedix (CRMD) over the last 9 years, with Dec 2024 value amounting to $137.

  • CorMedix's Preferred Shares fell 49.45% to $92 in Q3 2025 from the same period last year, while for Sep 2025 it was $92, marking a year-over-year decrease of 49.45%. This contributed to the annual value of $137 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Preferred Shares is $137, which was down 24.73% from $182 recorded in FY2022.
  • In the past 5 years, CorMedix's Preferred Shares ranged from a high of $242 in FY2020 and a low of $137 during FY2024.
  • Over the past 2 years, CorMedix's median Preferred Shares value was $159.50 (recorded in 2022), while the average stood at $159.50.
  • Data for CorMedix's Preferred Shares shows a maximum YoY fell of 24.79% (in 2021) over the last 5 years.
  • Over the past 4 years, CorMedix's Preferred Shares (Yearly) stood at $242 in 2020, then declined by 24.79% to $182 in 2021, then remained steady at $182 in 2022, then reached $137 in 2024.